Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs IRM✓SelectedUSD · IRMGSK vs IRM performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs IRM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
IRM return
+452.6%
Excess return
-355.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioIRMExcessAlpha
1D-0.1%-6.0%+5.9%+0.9%
7D-5.3%-10.1%+4.8%-3.7%
30D-3.7%-10.9%+7.2%-2.0%
3M-7.3%-16.2%+9.0%-4.8%
6M-4.2%-17.6%+13.3%-1.7%
YTD+0.9%+26.1%-25.2%-4.7%
1Y+7.3%+27.3%-20.0%+1.1%
3Y+52.7%+78.0%-25.2%+31.6%
5Y+40.1%+165.0%-124.9%+8.8%
All+97.1%+452.6%-355.5%+25.6%

Cumulative growth

Daily Returns

Daily percentage return beside IRM.

Daily Out/Under-Performance

Portfolio return minus IRM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × IRM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded IRM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling